Scott L. Kominsky

2.3k total citations
30 papers, 1.9k citations indexed

About

Scott L. Kominsky is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Scott L. Kominsky has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Scott L. Kominsky's work include Bone health and treatments (9 papers), Cancer-related Molecular Pathways (6 papers) and Epigenetics and DNA Methylation (5 papers). Scott L. Kominsky is often cited by papers focused on Bone health and treatments (9 papers), Cancer-related Molecular Pathways (6 papers) and Epigenetics and DNA Methylation (5 papers). Scott L. Kominsky collaborates with scholars based in United States, Netherlands and Switzerland. Scott L. Kominsky's co-authors include Saraswati Sukumar, Michèle Doucet, Dorian Korz, Pedram Argani, Kristy Weber, Venu Raman, Mustafa Vali, Alan Rein, Olli Kallioniemi and Elizabeth Garrett and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Scott L. Kominsky

29 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott L. Kominsky United States 22 921 689 554 480 232 30 1.9k
Gerhard Leder Germany 17 510 0.6× 469 0.7× 370 0.7× 304 0.6× 184 0.8× 32 1.4k
Stefania Canè Italy 23 619 0.7× 698 1.0× 174 0.3× 310 0.6× 197 0.8× 39 2.0k
Yoko Oei United States 12 1.4k 1.5× 1.1k 1.6× 379 0.7× 338 0.7× 278 1.2× 17 3.6k
Karim Y. Helmy United States 18 848 0.9× 407 0.6× 130 0.2× 464 1.0× 138 0.6× 20 2.2k
Eleanor B. Carson-Walter United States 16 861 0.9× 344 0.5× 86 0.2× 207 0.4× 126 0.5× 19 1.4k
Anat Erdreich‐Epstein United States 27 957 1.0× 311 0.5× 63 0.1× 380 0.8× 207 0.9× 60 1.9k
Agnieszka Looney United States 7 1.5k 1.6× 521 0.8× 138 0.2× 497 1.0× 539 2.3× 10 2.6k
Xiaohong Yao China 26 1.2k 1.3× 783 1.1× 78 0.1× 614 1.3× 160 0.7× 43 2.1k
Hee Jung An South Korea 27 1.3k 1.4× 818 1.2× 56 0.1× 766 1.6× 382 1.6× 76 2.5k
Yuuri Hashimoto Japan 24 834 0.9× 776 1.1× 74 0.1× 396 0.8× 370 1.6× 91 2.3k

Countries citing papers authored by Scott L. Kominsky

Since Specialization
Citations

This map shows the geographic impact of Scott L. Kominsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Kominsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Kominsky more than expected).

Fields of papers citing papers by Scott L. Kominsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Kominsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Kominsky. The network helps show where Scott L. Kominsky may publish in the future.

Co-authorship network of co-authors of Scott L. Kominsky

This figure shows the co-authorship network connecting the top 25 collaborators of Scott L. Kominsky. A scholar is included among the top collaborators of Scott L. Kominsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott L. Kominsky. Scott L. Kominsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doucet, Michèle, et al.. (2017). CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells. Oncology Letters. 15(1). 871–878. 15 indexed citations
2.
Doucet, Michèle, et al.. (2016). CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα. Molecular Cancer Research. 14(8). 730–739. 20 indexed citations
3.
Doucet, Michèle, et al.. (2016). Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA. Oncotarget. 8(4). 6169–6178. 11 indexed citations
4.
Han, Liangfeng, Adam Diehl, Nguyen K. Nguyen, et al.. (2014). The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk. Cancer Research. 74(22). 6509–6518. 27 indexed citations
5.
Lau, Wen Min, Michèle Doucet, David C.S. Huang, Kristy Weber, & Scott L. Kominsky. (2013). CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells. Biochemical and Biophysical Research Communications. 437(2). 261–266. 23 indexed citations
6.
Lau, Wen Min, et al.. (2013). Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis. PLoS ONE. 8(7). e66752–e66752. 55 indexed citations
7.
Weber, Kristy, et al.. (2012). MIP-1δ Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLCγ2 and NFκB Signaling. PLoS ONE. 7(7). e40799–e40799. 7 indexed citations
8.
Lau, Wen Min, Kristy Weber, Michèle Doucet, et al.. (2009). Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2. International Journal of Cancer. 126(4). 876–884. 24 indexed citations
9.
Kominsky, Scott L., et al.. (2008). Macrophage Inflammatory Protein–1δ: A Novel Osteoclast Stimulating Factor Secreted by Renal Cell Carcinoma Bone Metastasis. Cancer Research. 68(5). 1261–1266. 32 indexed citations
10.
Kominsky, Scott L., et al.. (2008). MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-β1. Clinical & Experimental Metastasis. 25(8). 865–870. 30 indexed citations
11.
Weber, Kristy, Michèle Doucet, & Scott L. Kominsky. (2007). Renal cell carcinoma bone metastasis—elucidating the molecular targets. Cancer and Metastasis Reviews. 26(3-4). 691–704. 31 indexed citations
12.
Kominsky, Scott L.. (2006). Claudins: emerging targets for cancer therapy. Expert Reviews in Molecular Medicine. 8(18). 1–11. 128 indexed citations
13.
Mironchik, Yelena, Paul T. Winnard, Farhad Vesuna, et al.. (2005). Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer. Cancer Research. 65(23). 10801–10809. 241 indexed citations
14.
Wu, Xinyan, Liangfeng Han, Scott L. Kominsky, & Saraswati Sukumar. (2005). Post-translation regulation inhibits Claudin-7 expression in invasive breast cancer cells.. Cancer Research. 65. 75–75.
15.
Kominsky, Scott L., Mustafa Vali, Dorian Korz, et al.. (2004). Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4. American Journal Of Pathology. 164(5). 1627–1633. 210 indexed citations
16.
Kominsky, Scott L., Pedram Argani, Dorian Korz, et al.. (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 22(13). 2021–2033. 372 indexed citations
17.
Kominsky, Scott L., et al.. (2000). Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.. PubMed. 60(14). 3904–8. 50 indexed citations
18.
Tanabe, Taishi, et al.. (2000). Inhibition of the Glioblastoma Cell Cycle by Type I IFNs Occurs at Both the G1 and S phases and Correlates With the Upregulation of P21WAF1/CIP1. Journal of Neuro-Oncology. 48(3). 225–232. 24 indexed citations
19.
Kominsky, Scott L., et al.. (2000). Inhibitory Effects of IFN-γ and Acyclovir on the Glioblastoma Cell Cycle. Journal of Interferon & Cytokine Research. 20(5). 463–469. 15 indexed citations
20.
Kominsky, Scott L., Howard M. Johnson, Taishi Tanabe, et al.. (1998). IFNγ inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1. Oncogene. 17(23). 2973–2979. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhard Leder Breakdown of academic impact, for papers by Stefania Canè Breakdown of academic impact, for papers by Yoko Oei Breakdown of academic impact, for papers by Karim Y. Helmy Breakdown of academic impact, for papers by Eleanor B. Carson-Walter Breakdown of academic impact, for papers by Anat Erdreich‐Epstein Breakdown of academic impact, for papers by Agnieszka Looney Breakdown of academic impact, for papers by Xiaohong Yao Breakdown of academic impact, for papers by Hee Jung An Breakdown of academic impact, for papers by Yuuri Hashimoto
Rankless by CCL
2026